Sfoglia per Rivista
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
2006-01-01 PIGA A; GALANELLO R; FORNI GL; CAPPELLINI MD; ORIGA R; ZAPPU A; DONATO G; BORDONE E; LAVAGETTO A; ZANABONI L; SECHAUD R; HEWSON N; FORD JM; OPITZ H; ALBERTI D
"REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA
2015-01-01 Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Luciano, L; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Avanzini, P; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Tiribelli, M; Rizzo, M; Endri, M; Antolino, A; Breccia, M; Vigneri, P; Trawinska, Mm; Guarini, A; Alimena, G
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
2001-01-01 Amabile, M; Giannini, B; Testoni, N; Montefusco, V; Rosti, G; Zardini, C; Terragna, C; Buonamici, S; Ottaviani, E; Soverini, S; Fiacchini, M; Bassi, S; de Vivo, A; Trabacchi, E; Saglio, G; Pane, F; Baccarani, M; Tura, S; Martinelli, G
I recettori ad attività tirosin kinasica EPHA3 come bersagli terapeutici nelle sindormi mieloproliferative croniche
2006-01-01 Chiarenza A; Messa F; Carturan S; Catalano R; Arruga F; Defilippi I; Rosso V; Serra A; Di Giovanni D; Nicoli P; Morotti A; Messa E; Bracco E; Martinelli G; Saglio G; Cilloni D
Recidiva locale tardiva a 20 anni dalla diagnosi di osteosarcoma tibiale
2004-01-01 A. BRACH DEL PREVER; A. COMANDONE; M. BERTA; S. FERRARI; A. BOGLIONE; E.M. BRACH DEL PREVER; G. GINO; M. PAGANO; M. MERCURI
RECONSTITUTION OF THE T CELL COMPARTMENT AND THE THYMIC FUNCTION AFTER REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
2012-01-01 B Bruno; P Omedè; S Cena; V Boccasavia; M Gilestro; L Cimolin; S Mattia; C Sfiligoi; L Giaccone; M Festuccia; F Ferrando; R Passera2; M Boccadoro
Recovery of cord blood hematopoietic progenitors after successive freezing and thawing procedures.
2003-01-01 Timeus F; Crescenzio N; Saracco P; Doria A; Fazio L; Albiani R; Cordero Di Montezemolo L; Perugini L; Incarbone E.
Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome.
1999-01-01 Cicilano M;Zecchina G;Roetto A;Bosio S;Infelise V;Stefani S;Mazza U;Camaschella C
REDUCED INTENSITY/NON-MYELOABLATIVE ALLOGRAFTING FOR HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA
2008-01-01 Giaccone L; Sorasio R; Fiore F; Bergui L; Resta I; Omedè P; Caltagirone S; Massaia M; Boccadoro M; Bruno B
Reduction of plasma fibrinolytic activity following high-dose cyclophosphamide is neutralized in vivo by GM-CSF administration.
1993-01-01 Bazzan M; Pannocchia A; Tarella C; Stella S; Garbarino G; Pileri A; Tamponi G
Regression of metastatic osteosarcoma following non-myeloablative stem cell transplantation. A case report.
2003-01-01 FAGIOLI F; BERGER M; BRACH DEL PREVER A; LIOJI S; AGLIETTA M; FERRARI S; PICCI P; MADON E.
Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and IL-4
2007-01-01 WILLIMOTT S; BAOU M; HUF S; DEAGLIO S; WAGNER SD
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET
2018-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Salvetti, C; Bomben, R; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Omede, P; Bonello, L; Kodipad, AA; Laurenti, L; Del Poeta, G; Mauro, FR; Bernardi, R; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET
2016-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, M; Omede, P; Ferretti, A; Del Poeta, G; Mauro, FR; Foa, R; Gattei, V; Gaidano, G; Boccadoro, M; Massaia, M; Coscia, M
REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE
2017-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, FR; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
Renal enlargement and prognosis of acute lymphoblastic leukemia in children: absence of correlations
1984-01-01 Pastore G; Saracco P; Miniero R; Artesani L; Listello G; Cordero di Montezemolo L; Madon E; Nicola P.
Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993.
1994-01-01 LANZA F ;MORETTI S ;PAPA S ;MALAVASI F ;CASTOLDI G
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
2007-01-01 SOVERINI S; COLAROSSI S; GNANI A; CASTAGNETTI F; ROSTI G; BOSI C; PAOLINI S; RONDONI M; PICCALUGA PP; PALANDRI F; GIANNOULIA P; MARZOCCHI G; LUATTI S; TESTONI N; IACOBUCCI I; CILLONI D; SAGLIO G; BACCARANI M; MARTINELLI G
RESULTS OF "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA
2014-01-01 Latagliata, R; Stagno, F; Annunziata, M; Iurlo, A; Scappini, B; Guarini, A; Giglio, G; Fava, C; Sora, F; Capodanno, I; Crugnola, M; Crescenzi, Sl; Barsotti, S; Feo, C; Breccia, M; Vigneri, P; Cambrin, Gr; Gozzini, A; Alimena, G
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients.
1996-01-01 LEVIS A ;DEPAOLI L ;BERTINI M ;BOTTO B ;CIRAVEGNA G ;FREILONE R ;GALLAMINI A ;GAVAROTTI P ;RICARDI U ;SCALABRINI DR ;SALOMONE A ;SALVI F ;VITOLO U ;PILERI A ;SANNAZZARI GL ;RESEGOTTI L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload | 2006 | PIGA A; GALANELLO R; FORNI GL; CAPPELLINI MD; ORIGA R; ZAPPU A; DONATO G; BORDONE E; LAVAGETTO A; ZANABONI L; SECHAUD R; HEWSON N; FORD JM; OPITZ H; ALBERTI D | |
| "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA | 2015 | Latagliata, R; Stagno, F; Annunziata, M; Abruzzese, E; Iurlo, A; Sgherza, N; Fava, C; Gozzini, A; Luciano, L; Giglio, G; Sora, F; Crescenzi, Sl; Bocchia, M; Crugnola, M; Gugliotta, G; Avanzini, P; Galimberti, S; Feo, C; Porrini, R; Pregno, P; Tiribelli, M; Rizzo, M; Endri, M; Antolino, A; Breccia, M; Vigneri, P; Trawinska, Mm; Guarini, A; Alimena, G | |
| Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia | 2001 | Amabile, M; Giannini, B; Testoni, N; Montefusco, V; Rosti, G; Zardini, C; Terragna, C; Buonamici, S; Ottaviani, E; Soverini, S; Fiacchini, M; Bassi, S; de Vivo, A; Trabacchi, E; Saglio, G; Pane, F; Baccarani, M; Tura, S; Martinelli, G | |
| I recettori ad attività tirosin kinasica EPHA3 come bersagli terapeutici nelle sindormi mieloproliferative croniche | 2006 | Chiarenza A; Messa F; Carturan S; Catalano R; Arruga F; Defilippi I; Rosso V; Serra A; Di Giovanni D; Nicoli P; Morotti A; Messa E; Bracco E; Martinelli G; Saglio G; Cilloni D | |
| Recidiva locale tardiva a 20 anni dalla diagnosi di osteosarcoma tibiale | 2004 | A. BRACH DEL PREVER; A. COMANDONE; M. BERTA; S. FERRARI; A. BOGLIONE; E.M. BRACH DEL PREVER; G. GINO; M. PAGANO; M. MERCURI | |
| RECONSTITUTION OF THE T CELL COMPARTMENT AND THE THYMIC FUNCTION AFTER REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2012 | B Bruno; P Omedè; S Cena; V Boccasavia; M Gilestro; L Cimolin; S Mattia; C Sfiligoi; L Giaccone; M Festuccia; F Ferrando; R Passera2; M Boccadoro | |
| Recovery of cord blood hematopoietic progenitors after successive freezing and thawing procedures. | 2003 | Timeus F; Crescenzio N; Saracco P; Doria A; Fazio L; Albiani R; Cordero Di Montezemolo L; Perugini L; Incarbone E. | |
| Recurrent mutations in the iron regulatory element of L-ferritin in hereditary hyperferritinemia-cataract syndrome. | 1999 | Cicilano M;Zecchina G;Roetto A;Bosio S;Infelise V;Stefani S;Mazza U;Camaschella C | |
| REDUCED INTENSITY/NON-MYELOABLATIVE ALLOGRAFTING FOR HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA | 2008 | Giaccone L; Sorasio R; Fiore F; Bergui L; Resta I; Omedè P; Caltagirone S; Massaia M; Boccadoro M; Bruno B | |
| Reduction of plasma fibrinolytic activity following high-dose cyclophosphamide is neutralized in vivo by GM-CSF administration. | 1993 | Bazzan M; Pannocchia A; Tarella C; Stella S; Garbarino G; Pileri A; Tamponi G | |
| Regression of metastatic osteosarcoma following non-myeloablative stem cell transplantation. A case report. | 2003 | FAGIOLI F; BERGER M; BRACH DEL PREVER A; LIOJI S; AGLIETTA M; FERRARI S; PICCI P; MADON E. | |
| Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and IL-4 | 2007 | WILLIMOTT S; BAOU M; HUF S; DEAGLIO S; WAGNER SD | |
| REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET | 2018 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Salvetti, C; Bomben, R; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Omede, P; Bonello, L; Kodipad, AA; Laurenti, L; Del Poeta, G; Mauro, FR; Bernardi, R; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M | |
| REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET | 2016 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, M; Omede, P; Ferretti, A; Del Poeta, G; Mauro, FR; Foa, R; Gattei, V; Gaidano, G; Boccadoro, M; Massaia, M; Coscia, M | |
| REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE | 2017 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, FR; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M | |
| Renal enlargement and prognosis of acute lymphoblastic leukemia in children: absence of correlations | 1984 | Pastore G; Saracco P; Miniero R; Artesani L; Listello G; Cordero di Montezemolo L; Madon E; Nicola P. | |
| Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993. | 1994 | LANZA F ;MORETTI S ;PAPA S ;MALAVASI F ;CASTOLDI G | |
| Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain | 2007 | SOVERINI S; COLAROSSI S; GNANI A; CASTAGNETTI F; ROSTI G; BOSI C; PAOLINI S; RONDONI M; PICCALUGA PP; PALANDRI F; GIANNOULIA P; MARZOCCHI G; LUATTI S; TESTONI N; IACOBUCCI I; CILLONI D; SAGLIO G; BACCARANI M; MARTINELLI G | |
| RESULTS OF "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA | 2014 | Latagliata, R; Stagno, F; Annunziata, M; Iurlo, A; Scappini, B; Guarini, A; Giglio, G; Fava, C; Sora, F; Capodanno, I; Crugnola, M; Crescenzi, Sl; Barsotti, S; Feo, C; Breccia, M; Vigneri, P; Cambrin, Gr; Gozzini, A; Alimena, G | |
| Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients. | 1996 | LEVIS A ;DEPAOLI L ;BERTINI M ;BOTTO B ;CIRAVEGNA G ;FREILONE R ;GALLAMINI A ;GAVAROTTI P ;RICARDI U ;SCALABRINI DR ;SALOMONE A ;SALVI F ;VITOLO U ;PILERI A ;SANNAZZARI GL ;RESEGOTTI L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile